Immunogold electron microscopy was used to examine human brain resections to localize the GLUTl glucose transporter. The tissue examined was obtained from a patient undergoing surgery for treatment of sei zures, and the capillary profiles examined had character istics identical to those described previously for active, epileptogenic sites (confirmed by EEG analyses). A rab bit polyclonal antiserum to the full-length human eryth rocyte glucose transporter (GLUTl) was labeled with 10nm gold particle-secondary antibody conjugates and lo calized immunoreactive GLUT1 molecules in human brain capillary endothelia, with <0.25% of the particles beyond the capillary profile. Erythrocyte membranes were also highly immunoreactive, whereas macrophage membranes were GLUT1-negative. The number of immu noreactive sites per capillary profile was observed to be 10-fold greater in humans than in previous studies of rat
Studies of convulsant-treated animals suggest that blood-brain barrier (BBB) glucose transport is up-regulated as a result of the seizure activity. This conclusion is suggested by observations that in vivo measurements of cerebral glucose utilization rates exceed the BBB glucose transporter maximal veloc ity in normally fed rats (Pard ridge , 1983) . One mechanism of up-regulation may involve selective translocation of glucose transporters from cytoplas mic to luminal membrane sites in the BBB (Corn ford et aI. , 1993) . As the GLUTl isoform is the principal glucose transporter in the BBB (Boado and rabbit brain capillaries. In addition, half of the total number of immunoreactive gold particles were localized to the luminal capillary membrane. We suggest that the blood-brain barrier GLUTl glucose transporter is up regulated in seizures, and this elevated transporter activ ity is characterized by increased GLUTl transporters, particularly on the luminal capillary membranes. In addi tion, acute modulation of glucose transporter activity is presumed to involve translocation of GLUT1 from cyto plasmic to luminal membrane sites, demonstrable with quantitative immunogold electron microscopy. Key Words: Acute up-regulation-Glucose transporter Glucose transporter recruitment-Human blood-brain barrier-Luminal membrane GLUTl-Seizures, tempo ral lobe-Subcellular immunogold electron microscopic localization. and Pardridge et aI., 1990) , intra cellular localization of transporter in brain capillar ies can be visualized using electron microscopic im munogold methods, in conjunction with a GLUTl specific antiserum.
Studies of the human BBB ultrastructure are lim ited by the availability of fresh material (Toussaint and Dustin, 1963) , and this requirement eliminates autopsies as a source of samples (Liwnicz et aI., 1990) . Since GLUTl immunogold electron micros copy additionally requires specialized tissue fixa tion and preparation (Farrell and Pardridge, 1991) , we obtained fresh surgically resected tissue from a seizure case in which a glioblastoma multiforme (GBM) was subsequently identified. Guerin et al. (1990) indicate 80% of capillary GLUTl is lost in these high-grade gliomas. Therefore, in a situation where any anticipated effect of the GBM would be to lower GLUTl , the present studies examine dis-tribution patterns to test the dual hypotheses of up regulation of total GLUTI transporter as a result of seizure activity and/or enhanced luminal membrane distribution of human BBB GLUTl transporters.
METHODS
Prior approval for this study had been obtained from the appropriate institutional review boards. The human brain tissue was obtained from a hospitalized patient with a 16-year history of complex partial seizures, with tonic clonic seizures in the last year. Despite treatment with therapeutic levels of both phenytoin (20 fJ.g/ml) and car bamazepine (9.8 fJ.g/ml), verified as recently as 3 days prior to surgery, the patient continued to have seizures. High-amplitude irregular slow and sharp waves were noted during presurgical workup EEG. Dexamethasone (0.57 mg/kg/day) had been administered for 7 days prior to surgery.
Small (1-3 mm3) blocks of the surgically resected tem poral lobe were immersion fixed as described by Farrell and Pardridge (1991) for immunogold localization studies. The fixative contained 2% paraformaldehyde in 0.05 or 0.1% glutaraldehyde, 0.9% NaCI, and 0.08 mg/ml CaCl2 in 0.01 M sodium phosphate buffer (pH 7.3). The brain tissue was placed in fixative as soon as possible after resection and further dissected into small (1 mm3) cubes. After further fixation at 4°C (1-2 h), it was placed in 0.1 M phosphate buffer (pH 7.3) overnight, then dehydrated and embedded in LR-white (Farrell and Pardridge, 1991) .
A rabbit antiserum to the purified human erythrocyte GLUTl glucose transporter (hGT), a 492-amino acid pep tide (Meuckler, 1990) , was prepared (Pard ridge et aI., 1990). The hGT was purified by the method of Baldwin and Lienhard (1989) . For immunogold staining, the anti hGT antiserum and the preimmune serum were both used at a dilution of 1 :800 (overnight at 4°C), and the secondary gold-conjugated goat anti-rabbit serum at 1:60 for 2 h (22°C). Two blocks were prepared for sectioning from each of the two pieces of temporal cortex. From electron micrographs of 19 capillaries, 15 complete immunogold stained microvessel profiles (averaging> 1 ,000 gold par ticles/profile) were analyzed with a Sigma Scan image analyzer. Gold particles were also counted on 11 profiles treated with immunogold-conjugated preimmune serum. Other procedures were previously described (Cornford et aI., 1993) .
RESULTS
In the human brain, capillary profiles were ob served to be highly immunoreactive to the GLUTl glucose transporter (Fig. 1) . The glucose trans porter was localized to the luminal membrane cir cumference, the abluminal membrane circumfer ence, and, to a lesser extent, the endothelial cyto plasm. In addition, the human erythrocyte membrane was also highly reactive ( Fig. 1) . At higher magnification, relatively more GLUTl im munoreactivity was present in the luminal than ab luminal membrane, in all of the capillary profiles examined from this temporal resection for seizures ( Fig. 2A) . The ultrastructure of the capillary pro-files we examined displayed characteristics seen (Liwnicz et al., 1990) in epileptogenically active (spiking) areas of the temporal cortex: thickened basement membrane-in many instances the thick ness of the basement membrane exceeds that of the endothelial cytoplasm; evidence of debris within the (thickened) basement membrane (Fig. 2B) ; and striated collagen fibers within the basement mem brane (Fig. 2C ). Note also that the human macro phage membrane (Fig. 2B ), unlike the erythrocyte (Fig. 1) , is GLUTl-negative. Capillary profiles and erythrocyte membranes stained with preimmune sera conjugated to gold particles are wholly nonre active (Fig. 3A ), and the difference is striking when compared with adjacent sections from the same capillary profile ( Fig. 3B ; stained with the hGT an tiserum).
Morphometric parameters of the capillary pro files were obtained from digital analyses ( Table 1) . The luminal membrane circumference is -85% of the abluminal membrane, but differences in length are not significant. However, we observed signifi cantly more GLUTI"immunoreactive gold particles on the luminal membrane (36 ± 111 flm) than on the abluminal membrane (22 ± 7/flm; p < 0.001, Stu dent's t test) circumference. The highly immunore active nature of the human capillary endothelial cell is also emphasized by the 50-fold greater number of gold particles associated with the endothelial cyto plasm than the neuropil (Table 1) . Furthermore, each profile exposed to hGT antiserum averaged 1,243 gold particles, in contrast to an average of 7 gold particles per profile for capillaries stained with immunogold conjugated to pre immune serum (Ta ble 2).
As indicated in Table 2 , in addition to the capil lary unit, the erythrocyte was the other GLUTl immunoreactive site we observed in our human brain sample. An average of 164 GLUTl -immuno reactive sites were seen per red cell, but only 8 ± 6 gold particles were observed associated with eryth rocytes treated with gold-conjugated preimmune se rum. In these red blood cells, 88 ± 8% of the total GLUTI immunoreactivity was localized to mem brane sites.
In BBB capillaries we examined, 82% of the GLUTl was membrane associated. The majority (47. 7%) was localized to the luminal membrane, 17.6% was cytoplasmic, and 34. 7% was localized to the abluminal capillary membrane (Table 1) .
DISCUSSION
Modulation of glucose transporter activity at the BBB may be attributable to either an alteration in the total capillary GLUTl (Cornford et al. , 1993 ;
FIG. 1. A capillary profile from a human surgical resection, where temporal lobe was removed as part of the treatment of a seizure disorder. This section was stained with immunogold particles conjugated to the human GLUT1 glucose transporter. Note that the entire capillary profile is highly immunoreactive, as is the erythrocyte (RBC) membrane. GLUT1 immunoreactivity is greatest at the luminal membrane, and to a lesser extent along the abluminal membrane circumference (indicated by filled arrows). Open arrows facing in opposite directions indicate the inner and outer limits of the basement membrane, which is thickened in response to the seizures (magnification x23,OOO). Dwyer and Pardridge, 1993) or acutely mediated through rapid translocation of capillary cytoplasmic GLUTl to the luminal membrane (suggested in Ta ble 1, Figs. 1-3 ). Since control human brain is not readily available, we assume the comparison of the number of gold particles per unit length of mem brane in human seizure, as compared to rat and rabbit, provides information on modulation of GLUTl at the BBB, as opposed to species differ ences. This assumption is supported by the data in Table 3 , which shows good correlations between cytochalasin B Bmax and membrane GLUTl immu noreactivity for animal brain capillaries and human red blood cells. Cytochalasin binding in the BBB of humans, rats, and rabbits also correlates with in vivo measurements of glucose transporter maximal velocities (Table 3) . Collectively these data would predict similarities between the number of immu nogold particles per micron on the normal human luminal BBB and rat and rabbit BBB luminal mem- 1994 branes. The percentage of gold particles in ablumi nal, cytoplasmic, and luminal membrane sites may also be anticipated to be similar. In contrast, we observed a > lO-fold increase in luminal gold (Table  3 ) and suggest this is attributable to the seizure dis order.
The most striking feature of the capillary immu noreactivity in this human seizure tissue was the dramatic GLUTl localization to the luminal capil lary membrane (Figs. 1, 2A, and 3B ). Almost one half (48%) of the total capillary transporter is lumi nal, another one third (35%) is associated with the abluminal membrane, and <20% remains in the cy toplasm (Table O . This asymmetrical distribution (favoring luminal over abluminal) was unexpected based on animal studies. Although GLUTl is sym metrically distributed in the dog (Gerhart et al., 1989) , an asymmetric distribution (favoring ablumi nal over luminal membrane) is generally observed (Dermietzel and Krause, 1991 . Note that the polymorphonuclear/macrophage (upper center) membrane, unlike the red blood cell (Fig. 1) , is not GLUT1-positive. The presence of debris (arrow) within a protuberant portion of the basement membrane (lower center) is typical of the spiking temporal cortex. Open arrows facing in opposite directions (in Figs. 28, 2C, 3A, and 38) Cornford et aI., 1993) . In the rat, for example, 45-53% of the GLUTl was abluminal, 11-13% luminal, and 34-44% cytoplasmic (Farrell and Pardridge, 1991) . Cunningham et al. (1986) suggested that BBB glu cose transport in vivo could be kinetically analyzed in terms of translocation via individual luminal and J Cereb Blood Flow Metab, Vol. 14, No.1, 1994 abluminal membranes as opposed to the traditional single-membrane model. Further support for the double-membrane model came from studies of glu cose transport in conscious and anesthetized states (Hargreaves et aI. , 1986) and in seizing (kainate treated) rats (Cremer et aI. , 1988) ; increasing asym metry between the luminal and abluminal BBB membrane permeability to glucose explained the metabolic up-regulation observed. These studies (Cunningham et aI., 1986; Hargreaves et aI. , 1986; Cremer et aI. , 1988) predicted membrane redistri butions of the glucose transporter, a concept em phasized by comparing abluminailluminal GLUTl ratios in normal animals and seizing humans (Ta  ble 3 ). The pathophysiology of the tissue sample we studied requires consideration of three important fa ctors: the GBM (astrocytoma grade IV), dexa methasone treatment, and epileptogenic foci. In GBM, 80% of the capillary GLUTl is lost (Guerin et aI. , 1990 ), but we observed high GLUTl reactiv ity in all BBB profiles. Furthermore, neuropatho logical review presented no indications of tumor (e. g., endothelial proliferation) in the capillaries we examined.
Dexamethasone treatment reduces GLUTI mRNA levels in both fat cells (Garvey et aI. , 1992) and brain endothelium (Farrell et aI. , 1992) . How- ever, in experimentally implanted gliomas, dexa methasone (3 mg/kg/day, 9 days) tends to restore cerebrovascular permeability characteristics and secondarily normalize brain capillary GLUTI im munoreactivity (Guerin et aI. , 1992) . Since both the high-grade glioma and dexamethasone treatment suppress GLUTI expression, we suggest the sei zure disorder is responsible for augmented GLUTl . Epileptogenic brain capillaries can be identified from analyses of biopsies obtained with concomi tant intraoperative EEG recordings (Liwnicz et aI. , 1990) . These authors provide three lines of evidence indicating that we examined BBB capillaries from an active, spiking, or seizing fo cus: (a) Liwnicz et aI. (1990) indicated most capillaries (>75%) from the epileptogenic focus had aggregates of cellular debris within the basement membrane, whereas this was seen in only 38% of the normal capillaries. We also observed cellular debris (see Fig. 3 ) within the basement membrane; the fact that it was GLUTl positive suggests that the origin of the debris may have been capillary endothelia, as well as represent ing degradation of pericytes (suggested by Liwnicz et aI. , 1990) . (b) Thickening of the capillary base ment membrane (see Figs. 1, 2B, and 3) in seizure foci was reported by Kasantikul et aI. (1983) , and subsequently Liwnicz et al. (1990) noted that thick ening at the capillary endothelial basement mem brane (designated BM-1) was greater than at the pericyte basement membrane (BM-3). We similarly observed thickening of the basement membranes (Table 1 ). (c) More than 35% of the capillaries from spiking foci contained striated collagen fibrils within the basement membrane, but this was ob served in <5% of the nons piking control capillaries (Liwnicz et aI. , 1990) . We observed this phenome non (see Fig. 2C ) in at least three different profiles examined. Consequently, since the tissue sample obtained in the present study was from a patient with a seizure history similar to those presented by Liwnicz et aI. (1990) , we conclude that the capillar ies examined in the present study came from an active epileptogenic focus.
Transporter recruitment in insulin-stimulated glu cose transport (in fat, skeletal muscle, and heart) occurs through a redistribution of the GLUT4 glu cose transporter isoform from intracellular sites to the cell surface (Mueckler, 1990) . Glucose 'trans porters translocate to the surface membranes in an oxic heart (Wheeler, 1988) , but the present study may be the first ultrastructural demonstration in the human.
Possible mechanisms for the regulation of human glucose transport include recruitment of GLUTI from cytoplasmic to membrane sites (Table 1) and 36. 2 ± 10. 9 0.61 1. 0 ± 0. 6' 3. 7 1. 5 ± 0. 6h 3. 3 13. 7 ± 5. 5
From aFeinendegen et al. (1986 ), bDick and Harik (1986 ), cPardridge (1983 ), dDick et al. (1984 , 'Farrell and Pardridge (1991) , fCornford and Cornford (1986) , gDwyer and ), hCornford et al. (1993 ), iSogin and Hinkle (1980 . up-regulation of total glucose transporters (Table  3 ). Further studies of capillary GLUTl transloca tion (cytosol-abluminal-Iuminal membrane) pat terns in other clinical cases are needed to confirm the hypothesis that this mechanism produces rapid up-and down-regulation of human BBB glucose transport and that the increased luminal GLUTl ob served is not seen in all human brain capillaries.
